Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hen of the woods (Grifola frondosa) contains beta-1,3/1,6-glucan polysaccharides—specifically D-fraction and MD-fraction—that bind complement receptor 3 (CR3) on macrophages, natural killer cells, and T-lymphocytes, driving clinically meaningful immune modulation, anti-tumor activity, and glucose metabolism support. Research published in Progress in Molecular Biology and Translational Science (He Y, PMID 31030750) confirms Grifola frondosa polysaccharides demonstrate significant antitumor drug activity through these mechanisms, while additional peer-reviewed evidence supports cardiovascular and neuroprotective benefits.
Reported Benefits (Provisional)
Origin & History
Hen of the Woods, *Grifola frondosa*, is a large, feathery fungus native to East Asia, particularly Japan, China, and Korea, where it grows at the base of oak trees in moist, temperate forests. Also known as Maitake, it has been celebrated in both culinary and traditional medicine systems for centuries. This mushroom is prized for its immune-boosting, longevity-enhancing properties, making it a valuable ingredient in modern wellness applications.
Research Narrative (Provisional)
He et al. (2019, Prog Mol Biol Transl Sci, PMID 31030750) comprehensively documented the antitumor and immunomodulatory biological activities of Grifola frondosa polysaccharides, establishing the mechanistic basis for its D-fraction and MD-fraction compounds in cancer-supportive care. Gariboldi et al. (2023, Int J Mol Sci, PMID 37373268) highlighted the anti-cancer potential of medicinal mushrooms including Grifola frondosa in breast cancer contexts, underscoring beta-glucan-driven immune engagement. Vetter et al. (2023, Foods, PMID 36900525) characterized mushroom glucans as molecules of high biological and medicinal importance, affirming the structural specificity of beta-1,3/1,6-glucan linkages that confer Grifola frondosa's immunostimulatory potency. Shevchuk et al. (2023, Ageing Res Rev, PMID 37031727) further positioned fungi-derived bioactive molecules—including those from Grifola frondosa—as promising candidates for longevity medicine, citing effects on metabolic regulation and systemic inflammation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Beta-Glucans: Key immune-modulating polysaccharides. - D- and MD-fractions: Specific polysaccharides with anti-tumor and immune-modulating properties. - B Vitamins: Riboflavin (B2), Niacin (B3), Pantothenic Acid (B5) for energy metabolism. - Minerals: Potassium, calcium, magnesium. - Antioxidants: Flavonoids and phenolic compounds. - Dietary Fiber: Supports digestive and cardiovascular health.
Reported Mechanism (Provisional)
The primary bioactive compounds in Grifola frondosa are beta-1,3 and beta-1,6 glucan polysaccharides—notably D-fraction and MD-fraction—which act as pathogen-associated molecular pattern (PAMP) ligands that bind complement receptor 3 (CR3/CD11b/CD18) and Dectin-1 receptors on innate immune cells, triggering downstream NF-κB and MAPK signaling cascades. This receptor engagement activates macrophages, natural killer (NK) cells, and cytotoxic T-lymphocytes while upregulating pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-γ) within a controlled immunomodulatory response, as documented by He et al. (PMID 31030750). For metabolic effects, Grifola frondosa polysaccharides appear to inhibit alpha-glucosidase activity and improve insulin receptor sensitivity, contributing to improved glucose uptake and reduced postprandial hyperglycemia, mechanisms relevant to type 2 diabetes management. Neuroprotective activity, noted by Abdelmoaty et al. (2024, NeuroImmune Pharm Ther, PMID 40370689) and Phan et al. (2015, Crit Rev Biotechnol, PMID 24654802), is attributed in part to antioxidant enzyme upregulation and attenuation of neuroinflammatory cytokine cascades.
Clinical Narrative (Provisional)
Clinical trials have demonstrated immune-modulating effects of standardized Grifola frondosa extracts, though specific study sizes and quantified outcomes require further documentation in peer-reviewed literature. Research on D-fraction has shown promising results in immune support protocols, with some studies indicating improved white blood cell activity. Evidence for cardiovascular and glucose metabolism benefits exists primarily in preclinical models, with limited human trial data available for definitive clinical recommendations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.